US · Healthcare · Health Information Services
EPS came in at -0.16 against a street estimate of -0.22 — a beat of 27.3%.
Analysts rate Heartflow, Inc. Common Stock a buy (8 buy, 2 hold, 0 sell out of 10) with an average price target of $46.00.
| Fund | Stake |
|---|---|
| Bain Capital Life Sciences Investors, LLC | 9.72% |
| Wellington Management Company LLP | 9.04% |
| BlackRock Inc | 5.98% |
| FMR Inc | 5.54% |
| Vanguard Portfolio Management, LLC | 4.12% |
| BAMCO Inc | 3.71% |
| Vanguard Capital Management, LLC | 3.17% |
| Jupiter Topco LLC | 2.78% |
| Document | Date |
|---|---|
| Quarterly report · Q2 2026 HEARTFLOW, INC. - FORM 10-Q SUMMARY Quarter Ended June 30, 2026 --- HEADLINE NUMBERS • Revenue (6 months): $116.7 million (up 44.7% vs $80.6 millio | 2026-08-13 |
| Results announced · Q3 2026 HEARTFLOW, INC. – Q2 2026 FINANCIAL SUMMARY HEADLINE NUMBERS • Q2 2026 Total Revenue: $64.1 million, up 48% year-over-year • U.S. Revenue: $59.6 mil | 2026-08-13 |
| Shareholder vote results · Q2 2026 HEARTFLOW, INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Annual Meeting held June 16, 2026 • Two Class I directors elected to three-year terms expiring | 2026-06-18 |
| Quarterly report · Q1 2026 HEARTFLOW, INC. - Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Revenue Q1 2026: $52.6 million (up 41% from $37.2 million in Q1 2025) • Net loss Q1 2026: | 2026-05-14 |
| Results announced · Q2 2026 HEARTFLOW, INC. – Q1 2026 FINANCIAL SUMMARY HEADLINE NUMBERS • Q1 2026 Total Revenue: $52.6 million, up 41% year-over-year - U.S. revenue: $48.3 m | 2026-05-14 |
| Proxy statement · Q2 2026 HEARTFLOW, INC. – 2026 PROXY STATEMENT SUMMARY WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1: Election of Two Class I Directors – Vote for Julie A. C | 2026-04-29 |
| Annual report FY2025 HEARTFLOW, INC. - 10-K SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Company: Heartflow, Inc. (Ticker: HTFL) - AI/software for diagnosing coronary | 2026-03-18 |
| Results announced · Q1 2026 HEARTFLOW, INC. – FINANCIAL SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Q4 2025 Revenue: $49.1 million, up 40% year-over-year • Full Year 2025 R | 2026-03-18 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Heartflow, Inc. Common Stock — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.